How to cite this paper
Ziyaev, A., Terenteva, E., Okmanov, R., Sasmakov, S., Toshmurodov, T., Khamidova, U., Umarova, M & Azimova, S. (2024). Synthesis and evaluation of cytotoxic and antimicrobial activity of some 3-aryl-6-phenyl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines.Current Chemistry Letters, 13(3), 549-556.
Refrences
1. Wang S., Gan X., Wang Y., Li S., Yi C., Chen J., He F., Yang Y., Hu D., and Song B. ( 2019) Novel 1,3,4-Oxadiazole Derivatives Containing a Cinnamic Acid Moiety as Potential Bactericide for Rice Bacterial Diseases. Int. J. Mol. Sci., 20 (5) 1020.
2. Tawfik S. S., Liu M., and Farahat A. A. (2020) Antiviral activity of thiadiazoles, oxadiazoles, triazoles and thiazoles. Arkivoc, part i, 180-218.
3. Abdelrehem E. M. (2021) Synthesis and Screening of New [1,3,4] Oxadiazole, [1,2,4] Triazole and [1,2,4] Triazolo [4,3 b][1,2,4] triazole Derivatives as Potential Antitumor Agents on the Colon Carcinoma Cell Line (HCT-116). ACS Omega, 6 (2) 1687-1696.
4. Abdel-Aziz M., Metwally K. A., Gamal-Eldeen A. M., and Aly O. M. (2015) 1,3,4-Oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities. Anticancer Agents Med Chem., 16 (2) 269-277.
5. Glomb T., Szymankiewicz K., and Swiatek P. (2018) Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole. Molecules, 23 (12) 3361.
6. Al-Wahaibi L. H., Mohamed A. A. B., Tawfik S. S., Hassan H. M., and El-Emam A. A. (2021) 1,3,4-Oxadiazole N-Mannich Bases: Synthesis, Antimicrobial, and Anti-Proliferative Activities. Molecules, 26 (8) 2110.
7. Nayak S., and Poojary B. (2020) Design, Synthesis, In Silico Docking studies, and antibacterial activity of some thiadiazines and 1,2,4-triazole-3-thiones bearing pyrazole moiety. Russ. J. Bioorg Chem., 46 (1) 97-106.
8. Ammar Y. A., Farag A. A., Ali A. M., Hessein S. A., Askar A. A., Fayed E. A., Elsisi D. M., and Ragab A. (2020) Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies. Bioorg Chem., 99 103841.
9. Strzelecka M., Swiatek P. (2021) 1,2,4-Triazoles as Important Antibacterial Agents. Pharmaceuticals, 14 (3) 224.
10. Alam M.M. (2022) 1,3,4-Oxadiazole as a Potential Anti-Cancer Scaffold: A Review. Bionterface Res. Appl. Chem., 12 (4) 5727-5744.
11. Ravinaik B., Ramachandran D., Rao M.V.B. (2019) Synthesis and Anticancer Evaluation of Amide Derivatives of 1,3,4-Oxadiazole Linked with Benzoxazole. Russ. J. Gen. Chem., 89 (5) 1003-1008.
12. Yurttaş L., Evren A.E., Kubilay A., Aksoy M.O., Temel H.E., Akalın Çiftçi G. (2023) Synthesis of Some New 1,3,4-Oxadiazole Derivatives and Evaluation of Their Anticancer Activity. ACS Omega, 8 (51) 49311-49326.
13. Alam M.M., Almalki S.A., Neamatallah T., Ali N.M., Malebari A.M., and Nazreen S. (2020) Synthesis of New 1,3,4-Oxadiazole-Incorporated 1,2,3-Triazole Moieties as Potential Anticancer Agents Targeting Thymidylate Synthase and Their Docking Studies. Pharmaceuticals, 13 (11) 390.
14. Çevik U.A., Sağlık B.N., Osmaniye D., Levent S., Çavuşoğlu B.K., Karaduman A.B., Eklioğlu Ö.A., Özkay Y., and Kaplancıklı Z.A. (2020) Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole - 1,3,4-oxadiazole derivatives as human topoisomerase types I poison. J Enzyme Inhib Med Chem., 35 (1) 1657-1673.
15. Myrko I., Chaban T., and Matiychuk V. (2022) Synthesis and biological evaluation of some new 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as antimicrobial agents. Curr. Chem. Lett., 11 (1) 75-82.
16. Xu Q., Bao K., Sun M., Xu J., Wang Y., Tian H., Zuo D., Guan Q., Wu Y., and Zhang W. (2017) Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors. Sci Rep, 7 11997.
17. Zhang B., Li Y. H., Liu Y., Chen Y. R., Pan E. S., You W. W., and Zhao P. L. (2015) Design, synthesis and biological evaluation of novel 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines bearing furan and thiophene nucleus. Eur J Med Chem., 103 335-342.
18. Farghaly T. A. E., Abdallah M. A., and Mmahmoud H. K. (2015) Synthesis of novel 1,2,4-triazoles and triazolo-thiadiazines as anticancer agents. Turk J Chem, 39 (5) 955-969.
19. Aggarwal R., Hooda M., Kumar P., and Sumran G. (2022) Vision on Synthetic and Medicinal Facetsof 1,2,4 Triazolo[3,4 b][1,3,4]thiadiazine Scaffold. Top Curr Chem, 380 10.
20. Ma W., Chen P., Huo X., Ma Y., Li Y., Diao P., Yang F., Zheng Sh., Hu M., You W., and Zhao P. (2020) Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: structure-activity relationship, in vitro and in vivo study. Eur J Med Chem., 208 112847.
21. Bhat K.S., Poojary B., Prasad D.J., Naik P., Holla B.S. (2009) Synthesis and antitumor activity studies of some new fused 1,2,4-triazole derivatives carrying 2,4-dichloro-5-fluorophenyl moiety. Eur J Med Chem., 44 (12) 5066-5070.
22. Ahmad A., Varshney H., Rauf A., Sherwani A., Owais M. (2017) Synthesis and anticancer activity of long chain substituted 1,3,4-oxadiazol-2-thione, 1,2,4-triazol-3-thione and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazine derivatives. Arab. J. Chem., 10 (2) S3347-S3357.
23. Mallisetty N.M., Allaka T.R., Ganipisetti H., Majhi D., Sirisilla R., and Putta N.N.K. (2022) Design, Synthesis, and Molecular Docking Study of 6-Aryl-3-(quinolin-3-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as Novel Antimicrobial Agents. Russ J Org Chem, 58 1851-1860.
24. Karande N.A., Rathi L.G., Kamble K.S., Nagar A., Gholve S., Bendale A.R., Danao K., and Bangre P.D. (2023) Synthesis, Anti-Inflammatory Activity and Molecular Docking Studies of New 1,2,4-Triazolo[3,4-b][1,3,4]Thiadiazine Derivatives. Pharm Chem J, 57 234-242.
25. Marathe S., Karnik A.V. (2017) Synthesis of 3-arylamino-6-phenyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivatives as potential bioactive molecules. Chem Heterocycl Comp, 53 (5) 604-607.
26. Ziyaev A. A., Makhmudov U. S., Ziyaeva M. A., and Tashkhodjaev B. (2017) Synthesis, crystal structures of S- and N-benzyl derivatives of 5-phenyl-1,3,4-oxadiazol-2-thione. Amer. J. of Curr. Org. Chem., 3 (1) 1-8.
27. Okmanov R. Y., Ziyaev A. A., Abdukarimov A. S., Toshmurodov T. T., and Kholikov T. S. (2023) Syntheses, crystal structures and Hirshfeld surface analysis of 2-(benzylsulfanyl)-5-[4-(dimethylamino)phenyl]-1,3,4-oxadiazole and 2-[(2-chloro-6-fluorobenzyl)sulfanyl]-5-[4-(dimethylamino)phenyl]-1,3,4-oxadiazole. Acta Cryst., E79, 552-556.
28. Ziyaev A. A., Sasmakov S. A., Toshmurodov T. T., Ziyaeva M. A.,. Abdurakhmanov J. M., Khasanov Sh. Sh., and Azimova Sh. S. (2023) Synthesis of S-(5-aryl-1,3,4-oxadiazol-2-yl) O-alkyl carbonothioate and alkyl 2-((5-aryl-1,3,4-oxadiazol-2-yl)thio)acetate, and their antimicrobial properties. JOTCSA, 10 (3) 599-604.
29. Zhang L.R., Liu Z.J., Zhang H., Sun J., Luo Y., Zhao T.T., Gong H.B., Zhu H.L. (2012) Synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives. Bioorg Med Chem., 20 (11) 3615-3621.
30. Abd-Ellah H.S., Abdel-Aziz M., Shoman M.E., Beshr E.A.M., Kaoud T.S., Ahmed A.F.F. (2017) New 1,3,4-Oxadiazole/Oxime hybrids: Design, Synthesis, anti-inflammatory, COX inhibitory activities and Ulcerogenic liability. Bioorg. Chem., 74 15-29.
31. Kulikov A.S., Epishina M.A., Fershtat L.L., and Makhova N.N. (2018) Effective synthesis of 7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines Chem Heterocycl Comp, 54 669-672.
32. Ismail M., Mohamady S., Samir N., and Abouzid K. (2020) Design, synthesis and biological evaluation of novel 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine inhibitors as antitumor agents. ACS Omega, 5 (32) 20170-20186.
33. Purohit D. H., Dodiya B. L., Ghetiya R. M., Piyush B. V., and Joshi H. S. (2011) Synthesis and antimicrobial activity of some new 1,3,4-thiadiazoles and 1,3,4-thiadiazines containing 1,2,4-Triazolo Nucleus. Acta Chim Slov., 58 (1) 53-59.
34. Li Z., Bai X., Deng Q., Zhang G., Zhou L., Liu Y., Wang J., and Wang Y. (2017) Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains. Bioorg Med Chem., 25 (1) 213-220.
35. Ding Q., Dai S., and Zhang L. X. (2018) Crystal structure of 3,6-diphenyl-7H-[1,2,4]-triazolo[3,4-b][1,3,4]thiadiazine, C16H12N4S. Zeitschrift für Kristallographie - New Crystal Structures, 233 (5) 849-851.
36. Yakaiah S., Durgaprasad K., Rao A., Rani P. B., Awantika S., Buchappa G., and Aparna P. (2016) Synthesis and cytotoxicity activity of novel benzotrizolyl methyl[1,2,4-triazolo][3,4-b]thiadiazinyl substituted chromene 2-ones. Asian J. Chem., 28 (6) 1381-1384.
37. El-Sayed H. A., Assy M. G., and Mohamed A. S. (2020) An efficient synthesis and antimicrobial activity of N-bridged triazolo[3,4-b]thiadiazine and triazolo[3,4-b]thiadiazole derivatives under microwave irradiation. Synth. Commun., 50 (7) 997-1007.
38. Aytac P. S., Durmaz I., Houston D. R., Çetin-Atalay R., and Tozkoparan B. (2016) Novel triazolothiadiazines act as potent anticancer agents in livercancer cells through Akt and ASK-1 proteins. Bioorg Med Chem., 24 (4) 858-872.
39. Khan I., Zaib S., Ibrar A., Rama N. H., Simpson J., and Iqbal J. (2014) Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. Eur J Med Chem., 78 167-177.
40. Razzoqova S. R., Kadirova S., Ashurov J. M., Rakhmonova D. S., Ziyaev A. А., and Parpiev N. A. (2019) 5-(3-Hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione hemihydrate. IUCrData, 4 (11) x191532.
41. Tozhiev I. F., Ziyaev A. A., and Shakhidoyatov Kh. M. (2012) Alkylation of 5-aryl-1,3,4-оxadiazol-2(3Н)-thions with allyl- and benzylhalogens. Chemistry and chemical technology, 4 17-20 (in Russian).
42. Krause L., Herbst-Irmer R., Sheldrick G. M., and Stalke D. (2015) Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination. J Appl Crystallogr., 48 (1) 3-10.
43. Sheldrick G. M. A short history of SHELX. (2008) Acta Crystallogr A., 64 (1) 112-122.
44. Sheldrick G. M. Crystal structure refinement with SHELXL. (2015) Acta Cryst, C71 3-8.
45. Niks M., and Otto M. (1990) Towards an optimized MTT assay. J Immunol Methods, 130 (1) 149-151.
46. Toshmurodov T., Ziyaev A., Sasmakov S., Abdurakhmanov J., Ziyaeva M., Ismailova D., and Azimova Sh. (2021) Amidoalkylation of heterocyclic amines by N-[5-(alkylsulfanyl)-1,3,4-thiadiazol-2-yl]- 2'-chloroacetamide and antimicrobial activity of derivatives. Curr. Chem. Lett., 10 (4) 427-434.